menu
    • menu

    Company profile for Covis Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Covis Pharmaceuticals is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. It is our mission to provide our customers with a continuous supply of safe, efficacious, and affordable therapeutic solutions. Covis Pharma, Sàrl, a Switzerland-based specialty pharmaceutical company is a supplier of Covis Pharmaceuticals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Covis PharmaLuxembourg Flag
    Country
    Country
    Luxembourg
    Address
    Address
    Atrium Business Park, 33 rue du Puits Romains, Bo?te 6, L-8070 Bertrange, Luxe...
    Telephone
    Telephone
    +1-844-749-1023
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://covispharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Covis’s Ferabright Receives Approval in US
    Covis’s Ferabright Receives Approval in US

    16 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219868

    FDA
    16 Oct 2025
    Share Share
    Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
    Azurity Pharmaceuticals Completes Acquisition of Covis Pharma

    14 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-completes-acquisition-of-covis-pharma-302401898.html

    PR NEWSWIRE
    14 Mar 2025
    Share Share
    FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic
    FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic

    01 May 2024

    // CNBC

    https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html

    CNBC
    01 May 2024
    Share Share
    Covis Announces Completion of Announced Financial Recapitalization Transaction
    Covis Announces Completion of Announced Financial Recapitalization Transaction

    01 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/01/2680107/0/en/Covis-Announces-Successful-Completion-of-Its-Previously-Announced-Financial-Recapitalization-Transaction-Resulting-in-a-Material-Strengthening-of-Its-Financial-Position.html

    GLOBENEWSWIRE
    01 Jun 2023
    Share Share
    US FDA withdraws approval for Covis Pharma's preterm birth prevention drug
    US FDA withdraws approval for Covis Pharma's preterm birth prevention drug

    07 Apr 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-withdraws-approval-covis-pharmas-preterm-birth-prevention-drug-2023-04-06/

    REUTERS
    07 Apr 2023
    Share Share
    Covis Statement on FDA Decision to Withdraw Approval of Makena®
    Covis Statement on FDA Decision to Withdraw Approval of Makena®

    07 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html

    GLOBENEWSWIRE
    07 Apr 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search